- When Time Meets Power
- Efficacy
- CV Protection
- EE Video Prof. Melanie Davies defining High & Very High risk patients
- Passive Cardio CV Safe is not Enough by Prof Davies
- Reduce the risk of CV death for T2D patients with high CV risk
- Defining HIGH risk and VERY HIGH risk patients with T2D
- Prof. Carvalho discussing CV Death reduction in EMPA-REG
- Unlocking The CRM link in T2D
- Empagliflozin's safety & tolerability profile vs DPP4i by Prof. Alice Cheng
- Holistic CRM management with Empaglifozin by Prof. Sanjay Kaul
- Empagliflozin safety & tolerability profile
- What's New in EMPRISE data?
- CV Risk Protection
- Seeing through the CV Risk Continuum: How Empagliflozin benefits patients across the spectrum
- EMPRISE RWE updates from ADA 2020
- Empagliflozin’s unique 38% CV death Risk reduction
- Empagliflozin beyond glucose lowering by Prof. Sanjay Kaul
- Unique CV death reduction of Empagliflozin
- Empagliflozin is more than just a T2D drug
- EMPA-REG Outcome Trial
- Guidelines
- Experts' Interview
- Expert's video
- How safe is Empagliflozin (JARDIANCE) in HFrEF
- Jardiance 10mg is Safe in Heart failure
- Empagliflozin (JARDIANCE) is simple and easy to use
- Consistent CV benefits in HFrEF
- Empagliflozin (JARDIANCE) in low eGFR HFrEF patients
- How Empagliflozin (JARDIANCE) 10 mg provide Cardio-Renal benefits in HFrEF
- Metabolism_Jardiance_EMPEROR-Preserved FAQ expert snippets - Carolyn Lam_video_15-7-22
- Advantages of Empagliflozin (JARDIANCE) in HFrEF
- EMPEROR-Preserved congress presentation video – Stefan Anker_video_15-7-22
- Metabolism_Jardiance_EMPEROR-Preserved FAQ expert snippets - Stefan Anker_video_15-7-22
- Empagliflozin (JARDIANCE) 10mg improves the quality of life in HFrEF
- Metabolism_Jardiance_EMPEROR-Preserved expert opinion and summary video_15-7-22
- Empagliflozin (JARDIANCE)'s Consistent CV and Renal Benefits in HFrEF
- Can you give Empagliflozin in HF patients with low eGFR?
- Empagliflozin (JARDIANCE) Early in HF management
- What is the clinical implication of Empagliflozin (JARDIANCE) in the full spectrum of HF?
- Empagliflozin (JARDIANCE) is safe in the full spectrum of HF with or without T2D
- Empagliflozin (JARDIANCE) provides consistent CV benefits across LVEF
- Empagliflozin (JARDIANCE) provides robust renal benefits in the full spectrum of HF
- Empagliflozin (JARDIANCE) improved the quality of life of HF patients
- JRDHF||What is the clinical implication of Empagliflozin in HF
- JRDHF||Renal efficacy and safety of Empagliflozin in HF
- JRDHF||How confident are you to start Empagliflozin to non-T2D HF patients?
- JRDHF||How early can you give Empagliflozin?
- JRDHF||How effective is Empagliflozin with or without ARNI?
- JRDHF||Early initiation to improve quality of life
- Prescribing Information
